OR-53: HMG-CoA reductase inhibitor improves endothelial dysfunction in mineralocorticoid hypertension by inhibition of RhoA

Hermann, Matthias; Ruschitzka, Frank; Camici, Giovanni; Shaw, Sidney; Luscher, Thomas F. (2003). OR-53: HMG-CoA reductase inhibitor improves endothelial dysfunction in mineralocorticoid hypertension by inhibition of RhoA. American journal of hypertension, 16(5), A24. Oxford University Press 10.1016/S0895-7061(03)00137-7

[img]
Preview
Text
16_S1_24A.pdf - Published Version
Available under License Publisher holds Copyright.

Download (38kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

Shaw, Sidney

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0895-7061

Publisher:

Oxford University Press

Language:

English

Submitter:

Markus Müller

Date Deposited:

26 Sep 2018 14:58

Last Modified:

02 Nov 2019 22:51

Publisher DOI:

10.1016/S0895-7061(03)00137-7

BORIS DOI:

10.7892/boris.114984

URI:

https://boris.unibe.ch/id/eprint/114984

Actions (login required)

Edit item Edit item
Provide Feedback